Smead Capital Management 13F holdings, Q4 2009
Holdings as of December 31, 2009 · filings on SEC EDGAR · latest filing →
Smead Capital Management disclosed 27 US equity positions worth $138.1m in its Q4 2009 13F filing. The largest position was Smead Value Fd at 14.2% of the reported book, followed by MSFT and Merck & Co Inc. Against the Q3 2009 filing, it opened 2 new positions, added to 7 and reduced 16 among the top 27 holdings.
What did Smead Capital Management own in Q4 2009? Top 27 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2009 |
|---|---|---|---|---|---|---|---|
| 1 | Smead Value Fd | 14.2% | $19.6m | 1,061,656 | 2% | added | |
| 2 | MSFT Microsoft Corp | Technology | 7.3% | $10.1m | 331,077 | -3% | reduced |
| 3 | Merck & Co Inc | 6.4% | $8.8m | 241,929 | -2% | reduced | |
| 4 | SBUX Starbucks Corp | Consumer Cyclical | 5.2% | $7.2m | 314,026 | -3% | reduced |
| 5 | DIS Disney Walt Co | Communication Services | 5.0% | $7.0m | 215,570 | -3% | reduced |
| 6 | BEN Franklin Resources Inc | Financial Services | 5.0% | $6.9m | 65,113 | -4% | reduced |
| 7 | EBAY Ebay Inc | Consumer Cyclical | 4.9% | $6.7m | 285,081 | 1% | added |
| 8 | Accenture Ltd | 4.6% | $6.4m | 153,825 | -3% | reduced | |
| 9 | WMT Wal-Mart Stores Inc | Consumer Defensive | 4.6% | $6.3m | 118,470 | -0% | held |
| 10 | PFE Pfizer Incorporated | Healthcare | 4.5% | $6.2m | 341,559 | -2% | reduced |
| 11 | T A T & T Inc New | Communication Services | 4.3% | $5.9m | 210,232 | -2% | reduced |
| 12 | VZ Verizon Communications | Communication Services | 4.2% | $5.8m | 175,913 | -3% | reduced |
| 13 | Nordstrom Inc | 4.0% | $5.5m | 145,240 | -2% | reduced | |
| 14 | HD Home Depot Inc | Consumer Cyclical | 3.8% | $5.3m | 181,967 | -2% | reduced |
| 15 | BMY Bristol-Myers Squibb Co | Healthcare | 3.0% | $4.2m | 164,585 | 8% | added |
| 16 | Walgreen Company | 2.8% | $3.9m | 106,999 | -2% | reduced | |
| 17 | MCD Mc Donalds Corp | Consumer Cyclical | 2.7% | $3.8m | 60,391 | -0% | held |
| 18 | PCAR Paccar Inc | Industrials | 2.4% | $3.4m | 93,326 | -2% | reduced |
| 19 | WFC Wells Fargo & Co New | Financial Services | 2.3% | $3.1m | 116,038 | 10% | added |
| 20 | CVX Chevron Corporation | Energy | 1.9% | $2.7m | 34,553 | -3% | reduced |
| 21 | GS Goldman Sachs Group Inc | Financial Services | 1.9% | $2.6m | 15,444 | -2% | reduced |
| 22 | Smead Value Fd Inst Cl | 1.1% | $1.5m | 81,337 | – | new | |
| 23 | Cabelas Inc | 1.0% | $1.4m | 98,287 | 23% | added | |
| 24 | Mylan Laboratories Inc | 0.8% | $1.1m | 60,127 | -1% | reduced | |
| 25 | Comcast Cp New | 0.8% | $1.1m | 67,722 | 115% | added | |
| 26 | Legg Mason Inc | 0.7% | $1.0m | 33,569 | 11% | added | |
| 27 | Gannett Co Inc Del | 0.5% | $706.0k | 47,574 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.